Why have physicians stopped routine screening for hyperuricemia and is there any value to this screening?
Articles by Staff
Letter: There’s No Reason Now to Screen for Uric Acid
Screening was common in the 1970s and before, but new studies demonstrate that most hyperuricemia patients never developed gout or kidney stones, so enthusiasm for screening waned
In Memoriam: Rheumatology Loses Dedicated Pediatric Rheumatologist
Suzanne L. Bowyer, MD served as chief of the division of rheumatology at the Riley Hospital for Children in Indianapolis and director of the fellowship program from 2003 until 2012
Why Universal Access to Healthcare Isn’t a Constitutional Right, It’s Just Plain Fair
One rheumatologist forms his opinion on the topic while fly fishing on rivers in Missouri
Blue Ribbon Panel on Academic Rheumatology Publishes Final Report
Report offers recommendations to address critical issues with training, practice, and research
The ACR’s Simple Tasks Campaign Expands its Reach, Launches a Blog, and Earns its Fourth Award
Simple Tasks exhibited at the annual meetings of two physician groups, and recently hand-delivered ACR materials to lawmakers on Capitol Hill
What You Need to Know About a Proposed Risk Evaluation and Mitigation Strategy Program for Opioid Analgesics
The U.S. Food and Drug Administration favors enacting a mandatory opioid-prescribing training program for dispensers of the extended-release and long-acting analgesics
ACR Adopts Strategic Plan to Advance Rheumatology
Recommendations in the areas of healthcare economics, rheumatology practice, and research are included in the ACR’s strategic plan for 2013 – 2016
Research into Methotrexate Could Lead to Improved Treatments for Rheumatoid Arthritis
With a grant from the ACR’s Rheumatology Research Foundation, Nancy J. Olsen, MD, hopes to discover how methotrexate interacts with immune system cells and ultimately helps to control the system’s attack on joints
ACR Advances Legislation to Increase Patients’ Access to Biologic Drugs to Treat Rheumatoid Arthritis and Other Conditions
The Patients’ Access to Treatments Act of 2013 would prevent insurance companies from tacking on an additional cost-sharing fee for the specialty medications
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 149
- Next Page »